PLoS Medicine (Apr 2017)

Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data.

  • Charles C White,
  • Hyun-Sik Yang,
  • Lei Yu,
  • Lori B Chibnik,
  • Robert J Dawe,
  • Jingyun Yang,
  • Hans-Ulrich Klein,
  • Daniel Felsky,
  • Alfredo Ramos-Miguel,
  • Konstantinos Arfanakis,
  • William G Honer,
  • Reisa A Sperling,
  • Julie A Schneider,
  • David A Bennett,
  • Philip L De Jager

DOI
https://doi.org/10.1371/journal.pmed.1002287
Journal volume & issue
Vol. 14, no. 4
p. e1002287

Abstract

Read online

IntroductionThe molecular underpinnings of the dissociation of cognitive performance and neuropathological burden are poorly understood, and there are currently no known genetic or epigenetic determinants of the dissociation.Methods and findings"Residual cognition" was quantified by regressing out the effects of cerebral pathologies and demographic characteristics on global cognitive performance proximate to death. To identify genes influencing residual cognition, we leveraged neuropathological, genetic, epigenetic, and transcriptional data available for deceased participants of the Religious Orders Study (n = 492) and the Rush Memory and Aging Project (n = 487). Given that our sample size was underpowered to detect genome-wide significance, we applied a multistep approach to identify genes influencing residual cognition, based on our prior observation that independent genetic and epigenetic risk factors can converge on the same locus. In the first step (n = 979), we performed a genome-wide association study with a predefined suggestive p ConclusionsThrough a multistep analysis of cognitive, neuropathological, genomic, epigenomic, and transcriptomic data, we identified ENC1 and UNC5C as genes with convergent genetic, epigenetic, and transcriptomic evidence supporting a potential role in the dissociation of cognition and neuropathology in an aging population, and we expanded our understanding of the TMEM106B haplotype that is protective against TDP-43 proteinopathy.